| Latent Labs Ltd.. (2/13/25). "Press Release: Latent Labs Secures $50M in Funding to Realize the Potential of AI-powered, Programmable Biology". London & San Francisco, CA. |
2025-02-13 |
| Newronika S.p.A.. (2/13/25). "Press Release: Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform". Milan. |
2025-02-13 |
| Bio-Rad Laboratories, Inc.. (2/13/25). "Press Release: Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies". Hercules, CA. |
2025-02-13 |
| Phaeosynt GmbH. (2/12/25). "Press Release: Phaeosynt Successfully Closes 1.7 Million Euro Seed Financing Round". Hannover. |
2025-02-12 |
| Anthos Therapeutics, Inc.. (2/11/25). "Press Release: Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 billion". Cambridge, MA. |
2025-02-11 |
| Novartis AG. (2/11/25). "Press Release: Novartis Bolsters Late-stage Cardiovascular Pipeline with Agreement to Acquire Anthos Therapeutics for USD 925 Million Upfront". Basel. |
2025-02-11 |
| Merck KGaA. (2/10/25). "Press Release: Merck Confirms Discussions with SpringWorks Therapeutics, Inc. on Potential Acquisition". Darmstadt. |
2025-02-10 |
| Mitsubishi Chemical Group Corporation. (2/7/25). "Press Release: Notice Concerning the Transfer of Mitsubishi Tanabe Pharma
Corporation and its Subsidiaries
". |
2025-02-07 |
| Bain Capital, LP. (2/7/25). "Press Release: Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation". Tokyo & Boston, MA. |
2025-02-07 |
| High-Tech Gründerfonds Management GmbH. (2/6/25). "Press Release: Modular. Data-driven. Connected. Avelios Medical Secures €30 Million from Sequoia Capital for Its Next-generation Hospital Information System". Munich. |
2025-02-06 |
| Tubulis GmbH. (2/6/25). "Press Release: Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.". Munich. |
2025-02-06 |
| Qureight Ltd.. (2/5/25). "Press Release: Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis". |
2025-02-05 |
| Becton, Dickinson and Company. (2/5/25). "Press Release: BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value". Franklin Lakes, NJ. |
2025-02-05 |
| Coulter Partners. (2/4/25). "Press Release: Coulter Partners Places Chief Business Officer at Our Future Health". |
2025-02-04 |
| High-Tech Gründerfonds Management GmbH. (2/4/25). "Press Release: Akribion Therapeutics Exits from Stealth with €8m Seed Financing to Pioneer RNA-guided, Programmable cell depletion". |
2025-02-04 |
| Evaxion Biotech A/S. (1/31/25). "Press Release: Evaxion Announces Closing of $10.8 Million Public Offering". Copenhagen. |
2025-01-31 |
| Rentschler Biopharma SE. (1/30/25). "Press Release: Rentschler Biopharma Announces Strategic Realignment of Its Global Business Operations". Laupheim. |
2025-01-30 |
| Tubulis GmbH. (1/30/25). "Press Release: Tubulis Announces First Patient Dosed in Phase I/IIa Trial Evaluating ADC TUB-030 in Advanced Solid Tumors". Munich. |
2025-01-30 |
| Evaxion Biotech A/S. (1/30/25). "Press Release: Evaxion Announces Pricing of $10.8 Million Public Offering". Copenhagen. |
2025-01-30 |
| Yumab GmbH. (1/29/25). "Press Release: Yumab and Inscreenex Get Funding for Innovative Mammalian Display Screening". Braunschweig. |
2025-01-29 |
| OSE Immunotherapeutics S.A.. (1/29/25). "Press Release: OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy". Nantes & Paris. |
2025-01-29 |
| TME Pharma N.V.. (1/29/25). "Press Release: TME Pharma Announces Collaboration with Aimed Analytics for AI-Driven Drug Discovery and Optimization". Berlin. |
2025-01-29 |
| Stryker. (1/28/25). "Press Release: Stryker Announces Definitive Agreement for the Sale of its U.S. Spinal Implants Business and Plans to Sell Related International Business". Portage, MI. |
2025-01-28 |
| Quibim S.L.. (1/28/25). "Press Release: Quibim Announces $50 Million in Series A Financing, Led by Asabys and Buenavista, to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers". Valencia & New York, NY. |
2025-01-28 |
| Evaxion Biotech A/S. (1/28/25). "Press Release: Evaxion Granted 180-day Compliance Extension by Nasdaq as It Restores Equity above Minimum Requirement". Copenhagen. |
2025-01-28 |
| Median Technologies S.A.. (1/24/25). "Press Release: Median Technologies Securing up to €47.5 Million to Support AI Lung Cancer Diagnostic Eyonis Regulatory Filings and Commercialization in U.S. and EU". Sophia Antipolis. |
2025-01-24 |
| Coulter Partners. (1/23/25). "Press Release: Coulter Partners Secures CEO Placement for NeoPhore". |
2025-01-23 |
| Körber Pharma. (1/23/25). "Press Release: Körber – Oliver Weber Appointed as CEO Software in the Business Area Pharma". Lüneburg. |
2025-01-23 |
| Medix Biochemica Oy. (1/22/25). "Press Release: Medix Biochemica Expands Its Offering of Critical IVD Raw Materials to Premium Blockers and Stabilizers by Acquiring Candor Bioscience". Espoo. |
2025-01-22 |
| Arctic Therapeutics. (1/22/25). "Press Release: Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing". Reykjavik & Philadelphia, PA. |
2025-01-22 |
| Circio Holding ASA. (1/21/25). "Press Release: 4basebio Partners with Circio to Build and Test circVec Synthetic DNA Vectors for Genetic Medicine and Vaccines". Oslo. |
2025-01-21 |
| Oryzon Genomics S.A.. (1/21/25). "Press Release: Oryzon Announces Appointment of Dr. Pierre Beaurang as Strategy and Business Development Advisor". Madrid & Cambridge, MA. |
2025-01-21 |
| Pharming Group N.V.. (1/21/25). "Press Release: Pharming to Nominate Biopharmaceutical Leader Fabrice Chouraqui as New Executive Director and Chief Executive Officer". Leiden. |
2025-01-21 |
| Cormica Ltd.. (1/20/25). "Press Release: Cormica Expands European Operations with Acquisition of Zwisler Laboratorium GmbH". |
2025-01-20 |
| Rentschler Biopharma SE. (1/16/25). "Press Release: Rentschler Biopharma Provides Update on Personnel Change in Company’s Extended Executive Team". |
2025-01-16 |
| Boehringer Ingelheim. (1/16/25). "Press Release: Boehringer Provides Update on Iclepertin Phase III Program in Schizophrenia". Ingelheim. |
2025-01-16 |
| Biosaxony e. V.. (1/16/25). "Press Release: Radiation Made in Saxony – Saxon Radiopharmacy Network nukliD Strengthens International Visibility". |
2025-01-16 |
| ITM Isotope Technologies Munich SE. (1/16/25). "Press Release: Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO". Chalk River, ON. |
2025-01-16 |
| Owlstone Medical Ltd.. (1/15/25). "Press Release: Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round". Cambridge. |
2025-01-15 |
| SGS S.A.. (1/15/25). "Press Release: Statement. Following Recent Media Commentary SGS Indicates that It Is in Discussions with Bureau Veritas Regarding a Potential Business Combination". |
2025-01-15 |
| Eckert & Ziegler SE. (1/14/25). "Press Release: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture". Berlin. |
2025-01-14 |
| European Invesmtent Bank (EIB). (1/14/25). "Press Release: Germany – EIB Provides €35 Million to Formo to Expand Production of Cheese Alternatives Free from Animal Products". |
2025-01-14 |
| BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg. |
2025-01-14 |
| Bioptimus SAS. (1/14/25). "Press Release: Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology". |
2025-01-14 |
| Forbion Capital Partners. (1/13/25). "Press Release: Forbion Promotes Dirk Kersten to Managing Partner and Strengthens US Team". Naarden. |
2025-01-13 |
| Normunity, Inc.. (1/13/25). "Press Release: Normunity Closes $75 million Series B Financing to Advance Lead Drug Program into the Clinic and Broaden Pipeline of Novel Anti-cancer Therapies Targeting Untapped Drug Mechanisms". Boston, MA & New Haven, CT. |
2025-01-13 |
| Cube Biotech GmbH. (1/13/25). "Press Release: Cube Biotech, Pioneer in Membrane Protein Production and Purification Technologies, Completes a Transformational Transaction with the Acquisition of IBA Lifesciences". Monheim. |
2025-01-13 |
| GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London. |
2025-01-13 |
| ITM Isotope Technologies Munich SE. (1/13/25). "Press Release: ITM and Ariceum Therapeutics Enter into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225". Garching, Munich & Berlin. |
2025-01-13 |
| Daiichi Sankyo Co., Ltd.. (1/13/25). "Press Release: Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH". Tokyo & Basking Ridge, NJ. |
2025-01-13 |
| bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux Strengthens Its Point of Care Presence with the Acquisition of the Immunoassay Start-up SpinChip". Marcy l’Étoile. |
2025-01-13 |
| Eckert & Ziegler SE. (1/13/25). "Press Release: Eckert & Ziegler and GlyTherix Extend Collaboration with Actinium-225 Supply Agreement". Berlin & Sydney. |
2025-01-13 |
| bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux to Present at the 43rd Annual J.P. Morgan HealthCare Conference". Marcy l’Étoile. |
2025-01-13 |
| Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
| RhyGaze AG. (1/10/25). "Press Release: Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration". Basel & Philadelphia, PA. |
2025-01-10 |
| CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA. |
2025-01-10 |
| BioLizard N.V.. (1/9/25). "Press Release: BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco". Ghent. |
2025-01-09 |
| Graph Therapeutics FlexCo. (1/9/25). "Press Release: Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for Immunological Diseases". Vienna. |
2025-01-09 |
| Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. |
2025-01-09 |
| Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen. |
2025-01-09 |
| Oribiotech Ltd.. (1/9/25). "Press Release: Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships". London. |
2025-01-09 |
| Astraveus SAS. (1/9/25). "Press Release: Astraveus Announces World First End-to-End Production of CAR-T Cells Using Microfluidic Technology". Paris. |
2025-01-09 |
| Medix Biochemica Oy. (1/8/25). "Press Release: Medix Biochemica Welcomes Stefan Schorling to Its Leadership Team". |
2025-01-08 |
| Alesta Therapeutics B.V.. (1/8/25). "Press Release: Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases". Leiden. |
2025-01-08 |
| Oribiotech Ltd.. (1/7/25). "Press Release: Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers". London. |
2025-01-07 |
| Argobio SAS. (1/7/25). "Press Release: Next-generation RNA Company Inverna Therapeutics Launched by Argobio and University of Southern Denmark". Odense. |
2025-01-07 |
| Senseera Ltd.. (1/7/25). "Press Release: Senseera Raises $7.1 Million Seed Round Led by Lightspeed Venture Partners". Jerusalem. |
2025-01-07 |
| Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2025-01-07 |
| Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2025-01-07 |
| Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen. |
2025-01-06 |
| Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou. |
2025-01-02 |
| Moldova Innovation Technology Park (MITP). (12/23/24). "Press Release: Moldova Innovation Technology Park Celebrates 7 Years. Driving 5% of Moldova’s GDP and Transforming the Tech Sector". |
2024-12-23 |
| Y-mAbs Therapeutics, Inc.. (12/23/24). "Press Release: Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference". New York, NY. |
2024-12-23 |
| Gemma Biotherapeutics. (12/23/24). "Press Release: GemmaBio Secures $34 Million in Seed Funding to Drive Gene Therapy Advancements". Philadeliphia, PA. |
2024-12-23 |
| Bruker Corporation. (12/20/24). "Press Release: Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility". Zürich. |
2024-12-20 |
| Idorsia Ltd.. (12/20/24). "Press Release: Idorsia Provides Update on the Exclusive Negotiations for the Global Rights to Aprocitentan". Allschwil. |
2024-12-20 |
| XGen Venture SGR S.p.A.. (12/19/24). "Press Release: XGen Venture Announces Final Closing of €180M ($190M) Life Sciences Fund". Milan. |
2024-12-19 |
| Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA. |
2024-12-19 |
| Sanofi S.A.. (12/19/24). "Press Release: Jean-Paul Kress to Join Sanofi’s Board of Directors". Paris. |
2024-12-19 |
| Roche. (12/18/24). "Press Release: Roche Transforms Mass Spectrometry Diagnostics with Launch of cobas Mass Spec Solution". Basel. |
2024-12-18 |
| BioAge Labs, Inc.. (12/18/24). "Press Release: BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions". Richmond, CA. |
2024-12-18 |
| Max Planck Innovation GmbH. (12/17/24). "Press Release: Christoph Hüls Becomes Managing Director of Max Planck Innovation GmbH, Succeeding Jörn Erselius, Who Is Retiring after more than 30 Years of Service". |
2024-12-17 |
| Merck KGaA. (12/17/24). "Press Release: Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio". Darmstadt. |
2024-12-17 |
| Evaxion Biotech A/S. (12/17/24). "Press Release: Evaxion Pursues Agreement with EIB to Bolster Equity through Conversion of Debt into Equity". Copenhagen. |
2024-12-17 |
| Wacker Chemie AG. (12/17/24). "Press Release: Wacker Biosolutions under New Leadership". Munich. |
2024-12-17 |
| Mainz Biomed N.V.. (12/16/24). "Press Release: Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering". Berkeley, CA & Mainz. |
2024-12-16 |
| Gilde Healthcare Partners. (12/16/24). "Press Release: Gilde Healthcare Invests alongside Capital A in Tromp Medical to Accelerate International Growth in the Medical Imaging Market". Utrecht. |
2024-12-16 |
| NeoPhore Ltd.. (12/16/24). "Press Release: NeoPhore Appoints Michael Shih as Chief Executive Officer". London. |
2024-12-16 |
| Single Use Support GmbH. (12/16/24). "Press Release: Darren Verlenden New CEO of Single Use Support". Kufstein. |
2024-12-16 |
| BetaGlue Therapeutics S.p.A.. (12/16/24). "Press Release: ENEA-Tech Biomedical Foundation Invests €6m in BetaGlue Therapeutics Bringing 2024 Funding Round Total to €24m". Milan. |
2024-12-16 |
| 2cureX AB. (12/16/24). "Press Release: 2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of Commercial Expansion of Breakthrough Precision Oncology Products". |
2024-12-16 |
| VectorY Therapeutics B.V.. (12/16/24). "Press Release: VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO". Amsterdam & Boston, MA. |
2024-12-16 |
| Pharming Group N.V.. (12/15/24). "Press Release: Pharming Announces Public Cash Offer to the Shareholders of Abliva AB". Leiden. |
2024-12-15 |
| Palvella Therapeutics, Inc.. (12/13/24). "Press Release: Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million". Wayne, PA. |
2024-12-13 |
| ITM Isotope Technologies Munich SE. (12/13/24). "Press Release: ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Garching / Munich. |
2024-12-13 |
| Eckert & Ziegler SE. (12/13/24). "Press Release: Eckert & Ziegler Submits GalliaPharm for Approval by Japan’s Health Authority MHLW". Berlin. |
2024-12-13 |
| Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. |
2024-12-12 |
| Kadans Science Partner. (12/12/24). "Press Release: Kadans Science Partner with the Support of Accumulata to Transform Former Signa Property into Life Science Innovation Hub". Berlin. |
2024-12-12 |
| EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
| Syncell, Inc.. (12/11/24). "Press Release: Syncell Announces $ 15 Million Series A Funding to Accelerate the Global Commercial Growth Of ITS Protein Purification And Spatial Proteomics Technology". Taipei & Watertown, MA. |
2024-12-11 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
